169 related articles for article (PubMed ID: 20135728)
1. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
Zhang Y; Zhou JH; Yin XL; Wang FY
World J Gastroenterol; 2010 Feb; 16(6):770-7. PubMed ID: 20135728
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
Zheng XY; Wei RB; Tang L; Li P; Zheng XD
World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
Wang WN; Wu MY; Ma FZ; Sun T; Xu ZG
Clin Nephrol; 2016 Jan; 85(1):21-9. PubMed ID: 26636326
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis.
Fu B; Ji Y; Hu S; Ren T; Bhuva MS; Li G; Yang H
PLoS One; 2020; 15(1):e0227532. PubMed ID: 31940324
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):781-8. PubMed ID: 16918881
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
[TBL] [Abstract][Full Text] [Related]
7. Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials.
Fabrizi F; Bruchfeld A; Mangano S; Dixit V; Messa P; Martin P
Int J Artif Organs; 2007 Mar; 30(3):212-9. PubMed ID: 17417760
[TBL] [Abstract][Full Text] [Related]
8. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
Yang Y; Ma YP; Chen DP; Zhuo L; Li WG
PLoS One; 2016; 11(9):e0160437. PubMed ID: 27598699
[TBL] [Abstract][Full Text] [Related]
9. [A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].
Zhu SS; Dong Y; Zhang HF; Wang LM; Xu ZQ; Zhang M; Gan Y; Chen DW; Wang FC; Yan JG; Zhao P
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):604-609. PubMed ID: 31594077
[No Abstract] [Full Text] [Related]
10. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Wiegand J; Wedemeyer H; Finger A; Heidrich B; Rosenau J; Michel G; Bock CT; Manns MP; Tillmann HL
Antivir Ther; 2008; 13(4):547-54. PubMed ID: 18672533
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: A systematic review and meta-analysis.
Yi Z; Jie YW; Nan Z
Ann Hepatol; 2011; 10(2):165-73. PubMed ID: 21502678
[TBL] [Abstract][Full Text] [Related]
12. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B.
Heijtink RA; Kruining J; Honkoop P; Kuhns MC; Hop WC; Osterhaus AD; Schalm SW
J Med Virol; 1997 Nov; 53(3):282-7. PubMed ID: 9365897
[TBL] [Abstract][Full Text] [Related]
13. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
Wiegand J; Hasenclever D; Tillmann HL
Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Serum DNA Replication, Clinicopathological Characteristics and Prognosis of Hepatitis B Virus-associated Glomerulonephritis with Severe Proteinuria by Lamivudine Plus Adefovir Dipivoxil Combination Therapy.
Jiang W; Liu T; Dong H; Xu Y; Liu LQ; Guan GJ; Liu XC
Biomed Environ Sci; 2015 Mar; 28(3):206-13. PubMed ID: 25800445
[TBL] [Abstract][Full Text] [Related]
15. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
Xia Y; Luo H; Liu JP; Gluud C
Cochrane Database Syst Rev; 2013 Apr; (4):CD009004. PubMed ID: 23633363
[TBL] [Abstract][Full Text] [Related]
16. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
van Nunen AB; Hansen BE; Suh DJ; Löhr HF; Chemello L; Fontaine H; Heathcote J; Song BC; Janssen HL; de Man RA; Schalm SW
Gut; 2003 Mar; 52(3):420-4. PubMed ID: 12584227
[TBL] [Abstract][Full Text] [Related]
17. Peginterferon-α2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.
Huang Z; Deng H; Zhao Q; Zheng Y; Peng L; Lin C; Zhao Z; Gao Z
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1165-9. PubMed ID: 23571612
[TBL] [Abstract][Full Text] [Related]
18. [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].
Zhou HJ; Li SG; Wen FY; Yang XY; Wu JL; Tan B; Fu J
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):564-8. PubMed ID: 19719911
[TBL] [Abstract][Full Text] [Related]
19. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
[TBL] [Abstract][Full Text] [Related]
20. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]